Effect of KAI1/CD82 on the β1 integrin maturation in highly migratory carcinoma cells

被引:32
|
作者
Jee, Bo Keun
Lee, Joo Yong
Lim, Young
Lee, Kweon Haeng
Jo, Yang-Hyeok
机构
[1] Catholic Univ, Dept Pharmacol, Socho Ku, Seoul 137701, South Korea
[2] Catholic Univ, Neurosci Genome Res Ctr, Socho Ku, Seoul 137701, South Korea
[3] Catholic Univ, Dept Occupat & Environm Med, St Marys Hosp, Seoul 137701, South Korea
[4] Catholic Univ, Dept Physiol, Socho Ku, Seoul 137701, South Korea
关键词
KAI1/CD82; tumor suppressor; cell migration; integrin beta 1; integrin maturation; H1299;
D O I
10.1016/j.bbrc.2007.05.159
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The KAI1/CD82 protein has been documented as the tumor metastasis suppressor in many types of human cancers. KAI1/CD82 regulates cell motility and invasiveness; however, the mechanism by which this occurs remains to be fully established. Several studies have shown that KAI1/CD82 modulates integrin-dependent signaling. It was suggested that KAI1/CD82 might function to attenuate the beta 1 integrin function of inducing cellular migration. A wound-healing and modified Boyden chamber assays were performed to investigate the mechanism of the KAI1/CD82-mediated inhibition of cell migration. It was found that the migratory ability of H1299/CD82 was inhibited. The immunoblotting and biotinylation assays revealed that H1299/CD82 showed significantly decreased expression of the mature form of PI, which was functional at the cell surface. It was confirmed that KAI1/CD82 regulates the maturation of the beta 1 integrin using CD82-specific si-RNA. These results support a model in which KAI1/CD82 attenuates the maturation of the beta 1 integrin precursor and thereby suppresses cell migration. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:703 / 708
页数:6
相关论文
共 50 条
  • [1] KAI1/CD82, a tumor metastasis suppressor
    Liu, Wei M.
    Zhang, Xin A.
    CANCER LETTERS, 2006, 240 (02) : 183 - 194
  • [2] Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma
    Wang, Gengming
    Jiang, Hao
    Xu, Hongbo
    Sun, Qian
    Zhou, Yan
    Xiang, Ping
    Cheng, Zenong
    Zhang, Yajun
    Zhou, Yufu
    Guo, Qing
    Du, Xinglong
    Xu, Shuxiu
    Ma, Shiyin
    Chen, Zhendong
    ONCOLOGY LETTERS, 2015, 9 (04) : 1681 - 1686
  • [3] KAI1/CD82与恶性肿瘤
    张英兰
    国外医学(肿瘤学分册), 2001, (04) : 271 - 273
  • [4] Normal Viability of Kai1/Cd82 Deficient Mice
    Risinger, John I.
    Custer, Mary
    Feigenbaum, Lionel
    Simpson, R. Mark
    Hoover, Shelley B.
    Webster, Joshua D.
    Chandramouli, Gadisetti V. R.
    Tessarollo, Lino
    Barrett, J. Carl
    MOLECULAR CARCINOGENESIS, 2014, 53 (08) : 610 - 624
  • [5] KAI1/CD82与肺癌的转移
    郑智
    国外医学(呼吸系统分册), 2003, (03) : 128 - 130
  • [6] Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma
    Yusenko, Maria V.
    Kovacs, Gyula
    HISTOPATHOLOGY, 2009, 55 (06) : 687 - 695
  • [7] Role of Metastasis Suppressor KAI1/CD82 in Different Cancers
    Yan, Wei
    Huang, Jinny
    Zhang, Qian
    Zhang, Jian
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [8] Dissecting the diverse functions of the metastasis suppressor CD82/KAI1
    Tsai, Yien Che
    Weissman, Allan M.
    FEBS LETTERS, 2011, 585 (20): : 3166 - 3173
  • [9] Expression of KITENIN, a KAI1/CD82 binding protein and metastasis enhancer, in bladder cancer cell lines: Relationship to KAI1/CD82 levels and invasive behaviour
    Rowe, Alexandra
    Jackson, Paul
    ONCOLOGY REPORTS, 2006, 16 (06) : 1267 - 1272
  • [10] Effects of KAI1/CD82 on biological behavior of human colorectal carcinoma cell line
    Li Liu Zu-Guo Li Guang-Zhi Yang Yan-Qing Ding Department of Pathology
    World Journal of Gastroenterology, 2003, 9 (06) : 1231 - 1236